Are dehydroepiandrosterone sulphate and lipids associated with erectile dysfunction?

Area of Science:

• Endocrinology
• Urology
• Gerontology

Background:

• Erectile dysfunction (ED) is a common concern in aging men.
• The Massachusetts Male Aging Study highlighted potential links between hormones and ED.
• Further investigation is needed to clarify the roles of dehydroepiandrosterone sulphate (DHEAS) and lipids in age-related ED.

Purpose of the Study:

• To investigate the relationship between dehydroepiandrosterone sulphate (DHEAS), testosterone, and lipid profiles in men with erectile dysfunction.
• To differentiate between age-related changes and causative factors in ED.
• To assess the impact of DHEAS and lipids on ED across different age groups.

Main Methods:

• A case-control study involving 40 males with ED and 17 healthy controls, stratified by age (<40 and >40 years).
• Serum levels of DHEAS, testosterone, total cholesterol, HDL-ch, LDL-ch, and triglycerides were measured.
• Statistical analysis was performed to compare levels between groups and assess correlations.

Main Results:

• Lower DHEAS levels were observed in men over 40 with ED compared to younger men with ED (P < 0.001).
• DHEAS showed an inverse correlation with age (r = -0.705) and a positive correlation with testosterone (r = +0.402).
• Men under 40 with ED had significantly higher total cholesterol and LDL-ch levels compared to controls (P < 0.01).

Conclusions:

• The decrease in DHEAS is primarily an age-related phenomenon, not a direct cause of ED.
• Elevated total cholesterol and LDL-ch may be contributing factors to ED, especially in younger men.
• Lipid management could be important in addressing ED in specific patient populations.